Hot Features
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminesc... Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -3.31 | -26.062992126 | 12.7 | 13.69 | 9.3 | 53698 | 11.64695395 | CS |
| 4 | -7.03 | -42.8136419001 | 16.42 | 18 | 9.3 | 55070 | 14.41905641 | CS |
| 12 | -18.74 | -66.6192676857 | 28.13 | 36.11 | 9.3 | 36048 | 20.60480101 | CS |
| 26 | -25.6 | -73.1637610746 | 34.99 | 44.44 | 9.3 | 45987 | 23.74526383 | CS |
| 52 | -42.23 | -81.8093762108 | 51.62 | 55.65 | 9.3 | 55324 | 33.01625125 | CS |
| 156 | 3.7288 | 65.8658941567 | 5.6612 | 55.65 | 5.32 | 71634 | 24.9755039 | CS |
| 260 | 3.7288 | 65.8658941567 | 5.6612 | 55.65 | 5.32 | 71634 | 24.9755039 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.